Trials / Completed
CompletedNCT03612804
Promoting Smoking Cessation in Lung Cancer Screening Through Proactive Treatment
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 944 (actual)
- Sponsor
- VA Office of Research and Development · Federal
- Sex
- All
- Age
- 80 Years
- Healthy volunteers
- Not accepted
Summary
This pragmatic trial will evaluate the value of routinely providing proactive smoking cessation support to current smokers as a part of participating in lung cancer screening within Veterans Health Administration.
Detailed description
This trial is a pragmatic randomized trial targeting the care of current smokers who are participating in lung cancer screening at two VA sites. Primary care providers at these sites will be randomized, and half will be offered tools to help integrate proactive smoking cessation support into the lung cancer screening process. Key proactive elements include proactive telephone outreach to all current smokers by a VA Quitline counselor that follows mailed results letters, and providing providers guidance in offering proactive cessation medication support as part of the lung cancer screening process.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Unsigned note to provider about cessation medication prescription | For patients of providers assigned to the proactive study group, a local coordinator will review the patient's cessation medication history. If the patient is not currently being provided cessation support medication, the coordinator will enter a note for the provider about the recommended medication indicated by VA formulary guidelines. |
| BEHAVIORAL | Proactive Telephone Counseling from VA Quitline | Patients of providers assigned to the proactive study group will be contacted by specially trained counselors at the VA Quitline. Counselors will attempt to provide two sessions of proactive telephone support. |
Timeline
- Start date
- 2019-05-10
- Primary completion
- 2023-02-09
- Completion
- 2023-02-09
- First posted
- 2018-08-02
- Last updated
- 2024-10-08
- Results posted
- 2024-10-08
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT03612804. Inclusion in this directory is not an endorsement.